JESSICA BATTAGLIA

Issues related to S.2296 - National Defense Authorization Act for Fiscal Year 2026 and H.R. 3838, the Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026 including servicing and repair of medical devices, outbound investment and BIOSECURE

Issues related to the taxation of multinational corporations corporations, including provisions of H.R. 1, the One Big Beautiful Bill Act

Issues related to global supply chains including rare earth and critical minerals Issues related to tariffs Issues related to Japan reimbursement

Issues related to global supply chains including critical minerals Issues related to tariffs

Issues related to the taxation of multinational corporations corporations and third party litigation funding, including provisions of H.R. 1, the One Big Beautiful Bill Act

Issues related to the taxation of multinational corporations

Issues related to global supply chains Issues related to tariffs

Issues related to the taxation of multinational corporations

Issues related to global supply chains Issues related to US-China trade

S.4638 - National Defense Authorization Act for Fiscal Year 2025, provisions related to Sec. 828 related to right to repair of medical devices and provisions related to outbound investment

Issues related to cybersecurity of medical devices, including S.4697 - Healthcare Cybersecurity Act of 2024

Issues related to global supply chains Issues related to US-China trade

Issues relating to the Foreign Agents Registration Act (FARA) including the Lobbying Disclosure Improvement Act (S. 264)

Issues related to disparities of care, including H.R. 880 - Heart Health Enhancement through Access to Research and Training Act Issues related to medical device electronic labeling, including H.R. 3723 - Medical Device Electronic Labeling Act Issues related to hypertension, including H.Res. 1232, supporting the goals and ideals of National Hypertension Month H.R.1328 - Medical Device Nonvisual Accessibility Act Issues related to the sterilization of medical devices Issues related to servicing and repair of medical devices Issues related to FDA device shortage reporting Issues related to FDA third-party review program Issues related to artificial intelligence and other advanced software in health care

Issues related to global supply chains Issues related to US-China trade

Issues related to cybersecurity S. 686, Restricting the Emergence of Security Threats that Risk Information and Communications Technology Act or the RESTRICT Act

Issues related to the taxation of multinational corporations

Monitoring Environmental, Social and Governance (ESG) issues relating to the health sector Issues related to the sterilization of medical devices, including the Department of the Interior, Environment, and Related Agencies Appropriations Act, 2024 Issues related to the use of polyfluoroalkyl substances, including H.R. 6805 the PFAS Action Act of 2023

Issues related to the taxation of multinational corporations

Issues related to global supply chains Issues related to US-China trade

Issues related to cybersecurity S. 686, Restricting the Emergence of Security Threats that Risk Information and Communications Technology Act or the RESTRICT Act

Issues related to the taxation of multinational corporations

Issues related to cybersecurity S. 686, Restricting the Emergence of Security Threats that Risk Information and Communications Technology Act or the RESTRICT Act

Issues related to global supply chains Issues related to US-China trade

Issues related to cybersecurity S. 686, Restricting the Emergence of Security Threats that Risk Information and Communications Technology Act or the RESTRICT Act

Issues related to the taxation of multinational corporations

Issues related to global supply chains Issues related to US-China trade Issues related to the Trade-Related Aspects of Intellectual Property Rights (TRIPS) waiver

Issues related to global supply chains Issues related to US-China trade Issues related to the Trade-Related Aspects of Intellectual Property Rights (TRIPS) waiver

Issues related to cybersecurity S. 686, Restricting the Emergence of Security Threats that Risk Information and Communications Technology Act or the RESTRICT Act

Issues related to the taxation of multinational corporations

Issues related to H.R. 6000, Cures 2.0 Act Issues related to global medical supply chains Issues related to opioid-induced respiratory compromise continuous patient monitoring, including H.R. 5932 - Inpatient Opioid Safety Act of 2021 Issues related to disparities of care Issues pertaining to FDA included in P.L. 117-328, the Consolidated Appropriations Act, 2023, including S.4348 - FDASLA Act of 2022, H.R.7667 - Food and Drug Amendments of 2022, S. 3799 - PREVENT Pandemics Act, S. 4391 - CLEAR Documentation Act - regarding certificates to foreign government, H.R. 8299/S. 4386 - regarding device change control plans, and H.R. 7084/A. 3983 -Patch Act of 2022, pertaining to cyber security of medical devices Issues related to the sterilization of medical devices Issues related to servicing and repair of medical devices Support for the Cardiovascular Advances in Research and Opportunity Legacy (CAROL) Act (H.R. 1193 and S. 1133) Issues related to Cancer Moonshot proposals

Monitoring the Federal Contracting for Peace and Security Act included in P.L. 117-263, the James M. Inhofe National Defense Authorization Act for Fiscal Year 2023

Monitoring H.R. 7185, Federal Contracting for Peace and Security Act

Issues related to H.R. 6000, Cures 2.0 Act Issues related to global medical supply chains Issues related to opioid-induced respiratory compromise continuous patient monitoring, including H.R. 5932 - Inpatient Opioid Safety Act of 2021 Issues related to disparities of care Issues pertaining to FDA, including S.4348 - FDASLA Act of 2022, H.R.7667 - Food and Drug Amendments of 2022, S. 3799 - PREVENT Pandemics Act, S. 4391 - CLEAR Documentation Act - regarding certificates to foreign government, H.R. 8299/S. 4386 - regarding device change control plans, and H.R. 7084/A. 3983 -Patch Act of 2022, pertaining to cyber security of medical devices Issues related to the sterilization of medical devices Issues related to servicing and repair of medical devices Support for the Cardiovascular Advances in Research and Opportunity Legacy (CAROL) Act (H.R. 1193 and S. 1133) Issues related to Cancer Moonshot proposals

Issues related to the taxation of multinational corporations H.R. 5376, Build Back Better Act

Issues related to H.R. 6000, Cures 2.0 Act Issues related to global medical supply chains Issues related to opioid-induced respiratory compromise continuous patient monitoring, including H.R. 5932 - Inpatient Opioid Safety Act of 2021 Issues related to disparities of care Issues pertaining to FDA, including S.4348 - FDASLA Act of 2022, H.R.7667 - Food and Drug Amendments of 2022, S. 3799 - PREVENT Pandemics Act, S. 4391 - CLEAR Documentation Act, and S. 4386 - regarding device change control plans and H.R. 7084/A. 3983 -Patch Act of 2022, pertaining to cyber security of medical devices Issues related to the sterilization of medical devices Issues related to servicing and repair of medical devices Support for the Cardiovascular Advances in Research and Opportunity Legacy (CAROL) Act (H.R. 1193 and S. 1133) Issues related to Cancer Moonshot proposals

Issues related to the taxation of multinational corporations. H.R. 5376, Build Back Better Act.

Issues related to stroke care and routing protocol policies pertaining to emergent large vessel occlusion stroke. Issues related to telemedicine and remote patient monitoring, including H.R.4670 - Advanced Safe Testing at Residence Telehealth Act of 2021. Issues related to global medical supply chains. Issues related to H.R. 6000, Cures 2.0 Act. Issues related to opioid-induced respiratory compromise continuous patient monitoring, including H.R. 5932 - Inpatient Opioid Safety Act of 2021. H.R. 7084 / S. 3983 - PATCH Act of 2022 Issues related to disparities of care. Issues pertaining to FDA, including medical device user fee reauthorization, certificates to foreign government, change control protocols, emerging signals, electronic labeling, and shortage reporting. Issues related to the sterilization of medical devices. Issues related to digital health, data interoperability, and electronic health records. Issues related to servicing and repair of medical devices Issues related to ONC and CMS implementation of effective and efficient interoperability standards. Support for the Cardiovascular Advances in Research and Opportunity Legacy (CAROL) Act (H.R. 1193 and S. 1133).

Issues related to the taxation of multinational corporations. H.R. 5376, Build Back Better Act.

Issues related to the sterilization of medical devices. Issues related to digital health, data interoperability, and electronic health records. Issues related to medical devices and COVID-19. Issues related to stroke care and routing protocol policies pertaining to emergent large vessel occlusion stroke. H.R. 5663, Safeguarding Therapeutics Act. Issues related to telemedicine and remote patient monitoring, including H.R.4670 - Advanced Safe Testing at Residence Telehealth Act of 2021. Issues related to global medical supply chains. Issues related to H.R. 6000, Cures 2.0 Act. Issues related to servicing of medical devices. Issues related to ONC and CMS implementation of effective and efficient interoperability standards. Issues related to opioid-induced respiratory compromise continuous patient monitoring, including H.R. 5932 - Inpatient Opioid Safety Act of 2021. Issues related to disparities of care. Support for the Cardiovascular Advances in Research and Opportunity Legacy (CAROL) Act (H.R. 1193 and S. 1133). Issue related to H.R. 5376, Build Back Better Act. Issues pertaining to FDA, including medical device user fee reauthorization.

Issues related to Medicare policies on continuous glucose monitors and closed loop systems. Issues related to opioid-induced respiratory compromise continuous patient monitoring. Issues pertaining to FY22 Inpatient Rule and LITT DRG reassignment. Issue related to Medicare coverage and payment for Breakthrough-designated medical devices, including H.R.4043 - Ensuring Patient Access to Critical Breakthrough Products Act. Issues related to telemedicine and remote patient monitoring. Issues related to Medicare prior authorization policies. Issues related to the coverage and payment of preventative screenings. Issues related to non-opioid pain therapies, including H.R. 3259/S. 586 (NOPAIN Act) and H.R. 4098/S. 1292 (Non-Opioid Directive Act). Issues related to Medicare coverage of digital health technologies. Issue related to The Build Back Better Act, A bill to provide for Reconciliation pursuant to title II of the concurrent Resolution on the Budget for Fiscal Year 2022 S. Con Res. 14.

Issues related to the sterilization of medical devices. Issues related to digital health, interoperability, and electronic health records. Issues related to medical devices and COVID-19. Issues related to stroke care and routing protocol policies pertaining to emergent large vessel occlusion stroke. H.R. 5663, Safeguarding Therapeutics Act. Issues related to telemedicine and remote patient monitoring. Issues related to global medical supply chains. Issues related to draft legislation for 21st Century Cures 2.0. S. 4473/H.R. 7956, Critical Medical Infrastructure Right to Repair Act of 2020. Issues related to ONC and CMS implementation of effective and efficient interoperability standards. Issues related to opioid-induced respiratory compromise patient monitoring. Support for the Amputation Reduction and Compassion Act (H.R. 2631 - ARC Act of 2021). Issues related to preventative health screenings. Issues related to disparities of care. Support for the Cardiovascular Advances in Research and Opportunity Lageacy (CAROL) Act (H.R. 1193 and S. 1133). Issues related to The Build Back Better Act, A bill to provide for Reconciliation pursuant to title II of the concurrent Resolution on the Budget for Fiscal Year 2022 S. Con Res. 14.

Issues related to value-based healthcare and modernization of fraud and abuse laws. Issues related to the sterilization of medical devices. Issues related to digital health, interoperability, and electronic health records. Issues related to medical devices and COVID-19. Issues related to stroke care and routing protocol policies pertaining to emergent large vessel occlusion stroke. H.R. 5663, Safeguarding Therapeutics Act. Issues related to telemedicine and remote patient monitoring. Issues related to global medical supply chains. Issues related to draft legislation for 21st Century Cures 2.0. S. 4473/H.R. 7956, Critical Medical Infrastructure Right to Repair Act of 2020. Issues related to ONC and CMS implementation of effective and efficient interoperability standards. Issues related to opioid induced respiratory compromise patient monitoring. Support for the Amputation Reduction and Compassion Act (H.R. 2631 - ARC Act of 2021). Issues related to preventative health screenings. Issues related to disparities of care. Support for the Cardiovascular Advances in Research and Opportunity Lageacy (CAROL) Act (H.R. 1193 and S. 1133).

Issues related to value-based healthcare and modernization of fraud and abuse laws. Issues related to the sterilization of medical devices. Issues related to digital health, interoperability, and electronic health records. Issues related to medical devices and COVID-19. Issues related to stroke care and routing protocol policies pertaining to emergent large vessel occlusion stroke. H.R. 5663, Safeguarding Therapeutics Act. Issues related to telemedicine and remote patient monitoring. Issues related to global medical supply chains. Issues related to draft legislation for 21st Century Cures 2.0. S. 4473/H.R. 7956, Critical Medical Infrastructure Right to Repair Act of 2020. Issues related to ONC and CMS implementation of effective and efficient interoperability standards. Issues related to opioid induced respiratory compromise patient monitoring. Support for the Amputation Reduction and Compassion Act. Issues related to the coverage and payment of preventative screenings. Issues related to disparities of care.

Tax issues related to supply chains. Issues related to the taxation of multinational corporations.

Issues related to value-based health care and modernization of fraud and abuse laws. Issues related to the sterilization of medical devices. Issues related to digital health, interoperability, and electronic health records. Issues related to medical devices and COVID-19. Issues related to stroke care and routing protocol policies pertaining to emergent large vessel occlusion stroke. S. 3468, Preventing Essential Medical Device Shortages Act. P.L 116-136, Coronavirus Aid, Relief, and Economic Security Act, provisions related to device shortage reporting. H.R. 5663, Safeguarding Therapeutics Act. H.R. 6049, Medical Supply Chain Security Act. Issues related to telemedicine and remote patient monitoring including the H.R. 7885, The RPM Access Act. Issues related to global medical supply chains. Issues related to draft legislation for 21st Century Cures 2.0. S. 4473/H.R. 7956, Critical Medical Infrastructure Right to Repair Act of 2020. Issues related to ONC and CMS implementation of effective and efficient interoperability standards.

Issues related to the Foreign Agents Registration Act (FARA)

Tax issues related to supply chains.

Issues related to global supply chains. Issues related to Section 301 tariffs.

Issues related to value-based health care and modernization of fraud and abuse laws. Issues related to the sterilization of medical devices. Issues related to digital health, interoperability, and electronic health records. Issues related to medical devices and COVID-19. Issues related to stroke care and routing protocol policies pertaining to emergent large vessel occlusion stroke. S. 3468, Preventing Essential Medical Device Shortages Act. P.L 116-136, Coronavirus Aid, Relief, and Economic Security Act, provisions related to device shortage reporting. H.R. 5663, Safeguarding Therapeutics Act. H.R. 6049, Medical Supply Chain Security Act. Issues related to telemedicine and remote patient monitoring. Issues related to global medical supply chains. Issues related to draft legislation for 21st Century Cures 2.0. S. 4473/H.R. 7956, Critical Medical Infrastructure Right to Repair Act of 2020. Issues related to ONC and CMS implementation of effective and efficient interoperability standards.

Tax issues related to supply chains.

Issues related to value-based health care and modernization of fraud and abuse laws. Issues related to the sterilization of medical devices. Issues related to digital health, interoperability, and electronic health records. Issues related to medical devices and COVID-19. Issues related to stroke care and routing protocol policies pertaining to emergent large vessel occlusion stroke. S. 3468, Preventing Essential Medical Device Shortages Act. P.L 116-136, Coronavirus Aid, Relief, and Economic Security Act, provisions related to device shortage reporting. H.R. 5663, Safeguarding Therapeutics Act. H.R. 6049, Medical Supply Chain Security Act. Issues related to telemedicine and remote patient monitoring. Issues related to global medical supply chains. Issues related to draft legislation for 21st Century Cures 2.0.

Issues related to implementation of (P.L. 115-97), the Tax Cuts and Jobs Act.

Issues related to value based health care and modernization of fraud and abuse laws. The Patient Affordability Value and Efficiency Act; issues pertaining to protections for value-based arrangements. Issues related to medical device, non-oral opioid pain treatment alternatives, including in implementation of the SUPPORT for Patients and Communities Act (P.L. 115-271) and H.R. 5172, the Non-Opioids Prevent Addiction in the Nation (NOPAIN) Act. Issues related to the sterilization of medical devices. Issues related to digital health, interoperability and electronic health records. Issues related to medical devices and COVID-19. Issues related to stroke care and routing protocol policies pertaining to emergent large vessel occlusion stroke. S. 3468, Preventing Essential Medical Device Shortages Act. H.R. 748, Coronavirus Aid, Relief, and Economic Security Act, provisions related to device shortage reporting. H.R. 5663, Safeguarding Therapeutics Act. H.R. 6049, Medical Supply Chain Security Act.

S. 692 and H.R. 2207, the Protect Medical Innovation Act, related to the repeal of the medical device tax. Issues related to implementation of P.L. 115-97, the Tax Cuts and Jobs Act. Issues related to H.R. 1865-Further Consolidated Appropriations Act, 2020.

Issues related to free trade agreements. Issues related to Executive Order 13873, Securing the Information and Communications Technology and Services Supply Chain.

Issues related to value based health care and modernization of fraud and abuse laws. The Patient Affordability Value and Efficiency Act; issues pertaining to protections for value-based arrangements. Issues related to medical device, non-oral opioid pain treatment alternatives, including in implementation of the SUPPORT for Patients and Communities Act (P.L. 115-271) and H.R. 5172, the Non-Opioids Prevent Addiction in the Nation (NOPAIN) Act. Issues related to the sterilization of medical devices. Issues related to interoperability and electronic health records.

Issues related to the Foreign Agents Registration Act (FARA).

Issues related to free trade agreements.

Issues related to Medicare policies on continuous glucose monitoring and artificial pancreas device systems. Issues related to value based health care and modernization of fraud and abuse laws. The Shared Accountability for Improved Patient Outcomes Act; The Patient Affordability Value and Efficiency Act; issues pertaining to protections for value-based arrangements. Issues related to breakthrough medical technologies. Issues related to S.2326, the New Opportunities for Value that Extend Lives (NOVEL) Act, regarding Medicare coverage for novel medical products.

Issues related to free trade agreements. Issues related to Section 301 proposed tariffs.

Issues related to value based health care and modernization of fraud and abuse laws. The Shared Accountability for Improved Patient Outcomes Act; The Patient Affordability Value and Efficiency Act; issues pertaining to protections for value-based arrangements. Issues related to medical device, non-oral opioid pain treatment alternatives, including in implementation of the SUPPORT for Patients and Communities Act (P.L. 115-271). Issues related to the sterilization of medical devices. Medical Device Safety Act (HR 2669), related to FDA federal preemption.

Issues related to free trade agreements. Issues related to Section 301 proposed tariffs.

H.R. 1, the For the People Act, provisions related to restrictions on U.S. subsidiary political engagement. Issues related to the Foreign Agents Registration Act (FARA).

S. 734, Internet of Things (IoT) Cybersecurity Improvement Act, provisions related to cybersecurity and medical technology. H.R. 1668, Internet of Things Resilience Partnership Act, provisions related to medical technology. Issues related to cybersecurity and medical technology.

S. 1656, Medical Device Cybersecurity Act, provisions related to cybersecurity and medical technology. S. 1691, Internet of Things (IoT) Cybersecurity Improvement Act, provisions related to cybersecurity and medical technology. S. 2020, The Cyber Shield Act, provisions related to cybersecurity and medical technology. H.R. 3985, Internet of Things Resilience Partnership Act, provisions related to medical technology. H.R. 4191, the HHS Cybersecurity Modernization Act, provisions related to cybersecurity and medical technology.

Issues related to free trade agreements. Issues related to Section 301 proposed tariffs.

S. 1656, Medical Device Cybersecurity Act, provisions related to cybersecurity and medical technology. S. 1691, Internet of Things (IoT) Cybersecurity Improvement Act, provisions related to cybersecurity and medical technology. S. 2020, The Cyber Shield Act, provisions related to cybersecurity and medical technology. H.R. 3985, Internet of Things Resilience Partnership Act, provisions related to medical technology. H.R. 4191, the HHS Cybersecurity Modernization Act, provisions related to cybersecurity and medical technology.

Issues related to free trade agreements. Issues related to proposed tariffs.

Issues related to competitive bidding for DME products. Issues related to Medicare policies on continuous glucose monitoring. Issues related to Medicare policies on drug coated balloons. Issues related to value based health care. Issues related to breakthrough medical technologies. Issues related to Medicare insulin pump claims.

S. 1656, Medical Device Cybersecurity Act, provisions related to cybersecurity and medical technology. S. 1691, Internet of Things (IoT) Cybersecurity Improvement Act, provisions related to cybersecurity and medical technology. S. 2020, The Cyber Shield Act, provisions related to cybersecurity and medical technology. H.R. 3985, Internet of Things Resilience Partnership Act, provisions related to medical technology. H.R. 4191, the HHS Cybersecurity Modernization Act, provisions related to cybersecurity and medical technology.

Issues related to price caps for medical technologies in India. Issues related to free trade agreements. Issues related to proposed tariffs.

S. 2098, the Foreign Investment Risk Review Modernization Act, provisions related to the Committee on Foreign Investment in the U.S. (CFIUS). H.R. 4311, the Foreign Investment Risk Review Modernization Act, provisions related to the Committee on Foreign Investment in the U.S. (CFIUS). S. 2039, the Disclosing Foreign Influence Act, provisions related to the Foreign Agents Registration Act (FARA). H.R. 4170, the Disclosing Foreign Influence Act, provisions related to the Foreign Agents Registration Act (FARA). S. 625, the Foreign Agents Registration Modernization and Enforcement Act, provisions related to the Foreign Agents Registration Act (FARA). H.R. 2811, the Foreign Agents Registration Modernization and Enforcement Act, provisions related to the Foreign Agents Registration Act (FARA). Issues related to sanctions.

S. 1656, Medical Device Cybersecurity Act, provisions related to cybersecurity and medical technology. S. 1691, Internet of Things (IoT) Cybersecurity Improvement Act, provisions related to cybersecurity and medical technology. S. 2020, The Cyber Shield Act, provisions related to cybersecurity and medical technology. H.R. 3985, Internet of Things Resilience Partnership Act, provisions related to medical technology. H.R. 4191, the HHS Cybersecurity Modernization Act, provisions related to cybersecurity and medical technology.

H.R. 1/P.L.115-97, The Tax Cuts and Jobs Act, international tax issues including OUS earnings and territorial tax reform proposals. H.R. 184, Protect Medical Innovation Act, provisions related to the continued suspension and repeal of the medical device tax. H.R. 4617, To amend the Internal Revenue Code of 1986 to provide for a temporary moratorium on the medical device excise tax, provisions related to the continued suspension and repeal of the medical device tax. S. 108, Medical Device Access and Innovation Protection Act, provisions related to the continued suspension and repeal of the medical device tax. Tax policy proposals relating to Puerto Rico. Issues related to foreign direct investment.

International tax issues including OUS earnings and territorial tax reform proposals. Issues related to the continued suspension and repeal of the medical device tax; H.R. 184, Protect Medical Innovation Act of 2017 and S. 108, Medical Device Access and Innovation Protection Act. Tax policy proposals relating to Puerto Rico. Issues related to foreign direct investment.

Issues related to cybersecurity for medical technology; S. 1656, Medical Device Cybersecurity Act of 2017 and S. 1691, Internet of Things (IoT) Cybersecurity Improvement Act of 2017.

Issues related to price caps for medical technologies in India. Issues related to free trade agreements.

Issues related to price caps for medical technologies in India. Issues related to free trade agreements.

International tax issues including OUS earnings and territorial tax reform proposals. Issues related to the continued suspension and repeal of the medical device tax. Tax policy proposals relating to Puerto Rico. Issues related to foreign direct investment.

H.R. 1628 - American Health Care Act, provision that would permanently repeal medical device excise tax. Senate Better Care Reconciliation Act (BCRA) of 2017, provision that would permanently repeal medical device excise tax. Issues related to opioids/chronic pain. Issues related to cybersecurity for medical technology. Issues related to value based health care and modernization of fraud and abuse laws. H.R. 2430 and S. 934, FDA Reauthorization Act of 2017. Issues related to consumer health information protection. S. 787, The Telehealth Innovation and Improvement Act of 2017. S. 870, Creating High Quality Results and Outcomes Necessary to Improve Chronic Care Act of 2017. Issues related to Heart Valve Disease. Issues related to continuous glucose monitoring.

Issues related to competitive bidding for DME products. Issues related to breakthrough device coverage/payment.

Issues related to regulatory issues in India. Issues related to free trade agreements.

International tax issues including OUS earnings and territorial tax reform proposals. Issues related to the continued suspension and repeal of the medical device tax. Tax policy proposals relating to Puerto Rico. Issues related to foreign direct investment.

S. 2943 - National Defense Act - provisions related to cybersecurity.

International tax issues including OUS earnings and territorial tax reform proposals. Issues related to foreign direct investment. Tax policy proposals relating to Puerto Rico. Issues related to the Treasury Department's proposed regulations on Section 385. Issues related to the continued suspension of the medical device tax.

Issues related to the Trans-Pacific Partnership Agreement.

International tax issues including OUS earnings and territorial tax reform proposals. Issues related to foreign direct investment. Tax policy proposals relating to Puerto Rico. Issues related to the Treasury Department's proposed regulations on Section 385. Issues related to the continued suspension of the medical device tax. Issues related to state taxation.

H.R. 1427/S.804 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. Issues related to competitive bidding for DME products. Issues related to physician-owned distributors. H.R. 5210/S. 2736 - Patient Access to Durable Medical Equipment Act - provisions related to patient access.

H.R. 1427/S.804 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. Issues related to competitive bidding for DME products. Issues related to physician-owned distributors. H.R. 5210/S. 2736 - Patient Access to Durable Medical Equipment Act - provisions related to patient access.

International tax issues including OUS earnings and territorial tax reform proposals. Issues related to foreign direct investment. Tax policy proposals relating to Puerto Rico. H.R. 5278 - Puerto Rico Oversight Management and Economic Stability Act (PROMESA) - provisions concerning the financial status of Puerto Rico. Issues related to the Treasury Departments' proposed regulations on Section 385. Issues related to the continued suspension of the medical device tax.

H.R. 1427 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. S. 804 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. Issues related to competitive bidding for DME products. Issues related to physician-owned distributors.

Issues relating to the negotiation of the Trans-Pacific Partnership Agreement. Issues relating to India market access.

International tax issues including OUS earnings and territorial tax reform proposals. Issues related to foreign direct investment. Tax policy proposals relating to Puerto Rico.

International tax issues including OUS earnings and territorial tax reform proposals. Issues related to foreign direct investment. Tax policy proposals relating to Puerto Rico.

Issues relating to the negotiation of the Trans-Pacific Partnership Agreement. Issues relating to India market access.

H.R. 1427 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. S. 804 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. Issues related to competitive bidding for DME products. Issues related to physician-owned distributors.

H.R. 160 - Protect Medical Innovation Act of 2015 - provisions related to the medical device tax. S.144 - Protect Medical Innovation Act - provisions related to the medical device tax. H.R. 3762 - Restoring Americans' Healthcare Freedom Reconciliation Act of 2015 - provisions related to the medical device tax. H.R. 2029 - Consolidated Appropriations Act of 2016 - provisions related to medical device tax delay. S. 1946 - Tax Relief Extension Act - provisions related to R & D tax credit. H.R. 34 - Tax Increase Prevention and Real Estate Investment Act of 2015 - sections related to expiring business tax provisions. International tax issues including OUS earnings and territorial tax reform proposals. Issues related to foreign direct investment. Issues related to the extension of expiring business tax provisions.

H.R. 1427 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. S. 804 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. Issues related to competitive bidding for DME products. Issues related to physician-owned distributors.

H.R. 1735 - National Defense Authorization Act of 2016 provisions related to federal contracting limitations

H.R. 160 - Protect Medical Innovation Act of 2015 - provisions related to the medical device tax. S.144 - Protect Medical Innovation Act - provisions related to the medical device tax. International tax issues including OUS earnings and territorial tax reform proposals. Issues related to foreign direct investment. Issues related to the extension of expiring business tax provisions.

H.R. 1427 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. S. 804 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. Issues related to competitive bidding for DME products. Issues related to physician-owned distributors.

H.R. 160 - Protect Medical Innovation Act of 2015 - provisions related to the medical device tax. S.144 - Protect Medical Innovation Act - provisions related to the medical device tax. International tax issues including OUS earnings and territorial tax reform proposals. Issues related to foreign direct investment. Issues related to the extension of expiring business tax provisions.

Issues relating to the negotiation of the Trans-Pacific Partnership Agreement. Issues related to statutory extension of Trade Promotion Authority. Issues that promote the competitiveness of the U.S. healthcare sector in international markets.

H.R. 1078 - The FDA Safety Over Sequestration Act and protecting industry using user fees from sequestration. H.R.160 - Protect Medical Innovation Act of 2015 - provisions related to the medical device tax. S. Con Res. 8 - provisions related to Medicare reimbursement and the repeal of the medical device excise tax. Issues related to Round One recompete and implications for diabetes products. Issues related to the 21st century cures draft, medical innovation and technology. Issues related to neuroscience research. Issues related to remote patient management and telehealth. Issues related to the humanitarian device exemption(HDE)/patient cap.

S. Con Res. 8 - provisions related to Medicare reimbursement and the repeal of the medical device excise tax.

Information sharing regarding the June 15, 2014 announcement by Medtronic to enter into a definitive agreement to acquire healthcare technology and medical supplies provider Covidien; Administrative Rules and Legislation Regarding Inversions and Related TransactionsProvided continuing support for Medtronic acquisition of Covidien, which included attention to potential legislation on federal contracting limitations and various tax policy proposals. S. 2260 - Expire Act - Expiring Provisions Improvement Reform & Efficiency Act - provisions related to extension of expiring tax provisions, such as the R&D tax credit Tax Reform Act of 2014 - provisions related to R&D credit, international tax issues, and territorial tax reform proposals

S.2825 - issues relating to the delivery of a controlled substance by a pharmacy to a practitioner

Issues relating to the negotiation of the Trans-Pacific Partnership Agreement Issues related to statutory extension of Trade Promotion Authority Issues that promote the competitiveness of the U.S. healthcare sector in international markets

S.2825 - issues relating to the delivery of a controlled substance by a pharmacy to a practitioner

Information sharing regarding the June 15, 2014 announcement by Medtronic to enter into a definitive agreement to acquire healthcare technology and medical supplies provider Covidien; Administrative Rules and Legislation Regarding Inversions and Related TransactionsS. 2260 - Expire Act - Expiring Provisions Improvement Reform & Efficiency Act - provisions related to extension of expiring tax provisions, such as the R&D tax credit Tax Reform Act of 2014 - provisions related to R&D credit, international tax issues, and territorial tax reform proposals

Issues relating to the negotiation of the Trans-Pacific Partnership Agreement Issues related to statutory extension of Trade Promotion Authority .

S. 232 - Medical Device Access and Innovation Protection Act - provisions related to the repeal of the medical device excise tax H.R. 523 - Protect Medical Innovation Act of 2013 - provisions related to the repeal of the medical device excise tax Expire Act - Expiring Provisions Improvement Reform & Efficiency Act - provisions related to extension of expiring tax provisions, such as the R&D tax credit, and repeal of the medical device excise taxTax Reform Act of 2014 - provisions related to R&D credit, international tax issues, including the taxation of foreign earnings of U.S. multinational corporations, and territorial tax reform proposals S. 1859 - Tax Extenders Act of 2013 - provisions related to extension of expiring tax provisions

S. 2360 & H.R. 4679 - Stop Corporate Inversion Act of 2014 - provisions related to US companies merging with foreign companies and reincorporating in foreign jurisdictions S. 2260 - Expire Act - Expiring Provisions Improvement Reform & Efficiency Act - provisions related to extension of expiring tax provisions, such as the R&D tax credit;Tax Reform Act of 2014 - provisions related to R&D credit, international tax issues, including the taxation of foreign earnings of U.S. multinational corporations, and territorial tax reform proposals Information sharing regarding the June 15, 2014 announcement by Medtronic that the company entered into a definitive agreement to acquire healthcare technology and medical supplies provider Covidien

Issues relating to the negotiation of the Trans-Pacific Partnership Agreement Issues related to statutory extension of Trade Promotion Authority. Issues that promote the competitiveness of the U.S. healthcare sector in international markets

Issues relating to the negotiation of the Trans-Pacific Partnership Agreement Issues related to statutory extension of Trade Promotion Authority .

S. 232 - Medical Device Access and Innovation Protection Act - provisions related to the repeal of the medical device excise tax H.R. 523 - Protect Medical Innovation Act of 2013 - provisions related to the repeal of the medical device excise tax Expire Act - Expiring Provisions Improvement Reform & Efficiency Act - provisions related to extension of expiring tax provisions, such as the R&D tax credit, and repeal of the medical device excise taxTax Reform Act of 2014 - provisions related to R&D credit, international tax issues, including the taxation of foreign earnings of U.S. multinational corporations, and territorial tax reform proposals S. 1859 - Tax Extenders Act of 2013 - provisions related to extension of expiring tax provisions

Education on reimbursement of medical devices in India Issues relating to the negotiation of the Trans-Pacific Partnership agreement Issues related to statutory extension of Trade Promotion Authority .

S. 232 - Medical Device Access and Innovation Protection Act - provisions related to the repeal of the medical device excise tax H.R. 523 - Protect Medical Innovation Act of 2013 - provisions related to the repeal of the medical device excise tax S. Con. Res. 8 - Senate Budget - provisions related to Medicare reimbursement and the repeal of the medical device excise taxP.L. 112-240 - American Taxpayer Relief Act of 2012 - provisions related to the repeal of the medical device excise tax Issues related to the R & D tax credit and corporate tax reform International tax issues, including the taxation of foreign earnings of U.S. multinational corporations and territorial tax reform proposals

S. 232 - Medical Device Access and Innovation Protection Act - provisions relating to the repeal of the medical device excise tax H.R. 523 - Protect Medical Innovation Act of 2013 - provisions relating to the repeal of the medical device excise tax S. Con. Res. 8 - Senate Budget - provisions relating to Medicare reimbursement and the repeal of the medical device excise taxP.L. 112-240 - American Taxpayer Relief Act of 2012 - provisions relating to the repeal of the medical device excise tax Issues related to the R & D tax credit and corporate tax reform International tax issues, including the taxation of foreign earnings of U.S. multinational corporations and territorial tax reform proposals

HR 2375, Transparency and Accountability in Medicare Bidding Act of 2013, provisions relating to round one recompete. HR 2810, the Medicare Patient Access and Quality Improvement Act of 2013 and issues relating to reform of SGR HR 2725, FDA Safety Over Sequestration Act of 2013, and S 1413 FDA User Fee Protection Act, protecting industry paid user fees from sequestrationHR 2663 & S. 1422 - The Preventative Health Savings Act, provisions that will permit leaders in Congress request that CBO estimate the long-term health savings that are possible from preventative health initiatives like Abdominal Aortic Aneurysm, Hypertension screenings. Issues related to FDA regulation of HIT and mobile applications Issues related to neuroscience research

HR 2375, Transparency and Accountability in Medicare Bidding Act of 2013, provisions relating to round one recompete. HR 2810, the Medicare Patient Access and Quality Improvement Act of 2013 and issues relating to reform of SGR HR 2725, FDAf Safety Over Sequestration Act of 2013, and S 1413 FDA User Fee Protection Act, protecting industry paid user fees from sequestrationHR 2663 & S. 1422 - The Preventative Health Savings Act, provisions that will permit leaders in Congress request that CBO estimate the long-term health savings that are possible from preventative health initiatives like Abdominal Aortic Aneurysms or Hypertension screenings. Issues related to FDA regulation of HIT and mobile applications Issues related to neuroscience research

S. 232 - Medical Device Access and Innovation Protection Act - provisions relating to the repeal of the medical device excise tax H.R. 523 - Protect Medical Innovation Act of 2013 - provisions relating to the repeal of the medical device excise tax S. Con. Res. 8 - Senate Budget - provisions relating to Medicare reimbursement and the repeal of the medical device excise taxP.L. 112-240 - American Taxpayer Relief Act of 2012 - provisions relating to the repeal of the medical device excise tax S. Con. Res. 8 - Senate Budget - provisions relating to the repeal of the medical device tax Issues related to the R & D tax credit and Corporate Tax Reform International tax issues, including the taxation of foreign earnings of U.S. multinational corporations and territorial tax reform proposals

S. 232 - Medical Device Access and Innovation Protection Act - provisions relating to the repeal of the medical device excise tax H.R. 523 - Protect Medical Innovation Act of 2013 - provisions relating to the repeal of the medical device excise taxP.L. 112-240 - American Taxpayer Relief Act of 2012 - provisions relating to the repeal of the medical device excise tax S. Con. Res. 8 - Senate Budget - provisions relating to the repeal of the medical device tax Issues related to the R & D tax credit and Corporate Tax Reform International tax issues, including the taxation of foreign earnings of U.S. multinational corporations and territorial tax reform proposals

HR 2375, Transparency and Accountability in Medicare Bidding Act of 2013, provisions relating to round one recompete. Issues related to mobile medical applications and neuroscience research.

Education on reimbursement of medical devices in India

S. 232 - Medical Device Access and Innovation Protection Act - provisions relating to the repeal of the medical device excise tax H.R. 523 - Protect Medical Innovation Act of 2013 - provisions relating to the repeal of the medical device excise taxP.L. 112-240 - American Taxpayer Relief Act of 2012 - provisions relating to the repeal of the medical device excise tax S. Con. Res. 8 - Senate Budget - provisions relating to the repeal of the medical device tax Issues related to the R & D tax credit and Corporate Tax Reform International tax issues, including the taxation of foreign earnings of U.S. multinational corporations and territorial tax reform proposals

H.R. 6156 - Russia and Moldova Jackson-Vanik Repeal Act of 2012 - Issues relating to extending Permanent Normal Trade Relations (PNTR) with Russia S. 3406 - Russia and Moldova Jackson-Vanik Repeal and Magnitsky Rule of Law Accountability Act of 2012 - Issues relating to extending Permanent Normal Trade Relations (PNTR) with Russia

S. 17 - Medical Device Access and Innovation Protection Act - provisions relating to the repeal of the medical device excise tax H.R. 436 - Protect Medical Innovation Act of 2011 - provisions relating to the repeal of the medical device excise tax S. 3521, The Family & Business Tax Cut Certainty Act of 2012 - Provisions relating to the extension of the R&D tax credit. P.L. 112-240 (H.R. 8), The American Taxpayer Relief Act of 2012 - Provisions relating to the medical device tax and the R& D tax credit. Issues related to the taxation of medical devices, the R&D tax credit, and corporate tax reform. International tax issues, including, the taxation of foreign earnings of U.S. multinational corporations, and territorial tax reform proposals.

P.L. 111-148 - Patient Protection and Affordable Health Care Act - provisions relating to the implementation of this Act including Accountable Care Organizations, Physician Payment Disclosure, Patient Centered Outcomes Research Institute (PCORI), and other issues P.L. 112-144 - the Food and Drug Administration Safety and Innovation Act - provisions relating to the implementation of this Act including the medical device user fee program S. 3187 - Food and Drug Administration Reform Act of 2012 - provisions relating to medical device user fees H.R. 5651 - Food and Drug Administration Reform Act of 2012 - provisions relating to medical device user fees S. 2516 - the Food and Drug Administration Safety and Innovation Act - provisions relating to medical device user fees

S. 17 - Medical Device Access and Innovation Protection Act - provisions relating to the repeal of the medical device excise tax H.R. 436 - Protect Medical Innovation Act of 2011 - provisions relating to the repeal of the medical device excise tax S. 3521, The Family & Business Tax Cut Certainty Act of 2012 - Provisions relating to the extension of the R&D tax credit. Issues related to the taxation of medical devices, the R&D tax credit, and corporate tax reform. International tax issues, including, the taxation of foreign earnings of U.S. multinational corporations, and territorial tax reform proposals.

S. 17 - Medical Device Access and Innovation Protection Act - provisions relating to the repeal of the medical device excise tax H.R. 436 - Protect Medical Innovation Act of 2011 - provisions relating to the repeal of the medical device excise tax S. 239 - Innovate America Act - provisions relating to regulatory and tax improvement H.R. 3630 - Middle Class Tax Relief and Job Creation Act (formerly the Temporary Payroll Tax Cut Continuation Act of 2011) - provisions relating to the R & D tax credit Issues related to the taxation of medical devices, the R&D tax credit, and corporate tax reform. International tax issues, including, the taxation of foreign earnings of U.S. multinational corporations, and territorial tax reform proposals.

Issues relating to extending Permanent Normal Trade Relations (PNTR) with Russia Issues relating to preserving the 2010 US-Brazil temporary agreement to avoid trade retaliation against US medical device sector. Issues relating to improving medical device regulation in India. Issues relating to improving reimbursement regulations in Taiwan.

S. 365 - Budget Control Act of 2011 - provisions relating to Medicare reimbursement

S. 17 - Medical Device Access and Innovation Protection Act - provisions relating to the repeal of the medical device excise tax S. 262 - provisions relating to the repeal of the medical device excise tax H.R. 436 - Protect Medical Innovation Act of 2011 - provisions relating to the repeal of the medical device excise tax H.R. 488 - Save Our Medical Devices Act of 2011 - provisions relating to the repeal of the medical device excise tax H.R. 734 - provisions relating to the repeal of the medical device excise tax S. 239 - Innovate America Act - provisions relating to regulatory and tax improvement H.R. 3630 - Middle Class Tax Relief and Job Creation Act (formerly the Temporary Payroll Tax Cut Continuation Act of 2011) - provisions relating to the R & D tax credit Issues related to the taxation of medical devices, the R&D tax credit, and corporate tax reform. International tax issues, including, the taxation of foreign earnings of U.S. multinational corporations, and territorial tax reform proposals.

Issues related to pending Free Trade Agreements with Korea, Colombia & Panama

Patient Protection and Affordable Health Care Act (P.L. 111-148) - Issues relating to the implementation of this Act including Accountable Care Organizations, Physician Payment Disclosure, Patient Centered Outcomes Research Institute (PCORI), and other issues. S. 17/ H.R. 436 - Medical Device Access and Innovation Act - issues relating to the repeal of the medical device excise tax S. 239 - Innovate America Act - Provisions relating to regulatory and tax improvement H.R. 3211 - Humanitarian Device Reform Act of 2011 - Improve humanitarian device regulation and foster device development for rare diseases. S. 1865 - Patient Access to Medical Innovation Act - Improve humanitarian device regulation and foster device development for rare diseases. H.R. 3209 - Premarket Predictability Act of 2011 - Provisions relating to a new streamlined review of new devices, require reviewers to provide scientific or regulatory rationale for major decisions and establish an expedited approval appellate process, and the establishment of the two Investigational Device Exemption pathways. H.R. 3203 - Novel Device Regulatory Relief Act of 2011 - Streamlines the de novo classification process by striking the requirement that an applicant submit a 510(k) application before entering the de novo process. H.R. 3206 - Cultivating Scientific Expertise to Foster Innovation for Patients Act of 2011 - Fixes the FDA's conflict of interest policies to ensure the most knowledgeable experts are able to serve on FDA advisory committees. H.R. 3214 - Food and Drug Amdinistration Mission Reform Act of 2011 - establishes a regulatory system that is accessible, consistent and transparent, promotes predictability, allows flexibility and reduces uncertainty, facilitates innovation, protects public health and enables patients accessto novel products, and incorporates a patient-focused, risk-benefit framework to ensure the FDA takes them into account. H.R. 3205 - FDA Renewing Efficiency From Outside Reviewer Management Act of 2011 - Reauthorizes the third party inspection program and reforms the third party review program to foster better participation, decrease approval times and conserve FDA resources. Issues pertaining to Congressional Oversight inquiries from the Senate Finance Committee. Issues relating to the FDA 510(k) review process for medical devices.

Patient Protection and Affordable Health Care Act (P.L. 111-148) - Issues relating to the implementation of this Act including Accountable Care Organizations, Physician Payment Disclosure, Patient Centered Outcomes Research Institute (PCORI), and other issues. S. 17/ H.R. 436 - Medical Device Access and Innovation Act - issues relating to the repeal of the medical device excise tax S. 239 - Innovate America Act - provisions relating to regulatory and tax improvement Humanitarian Device Reform legislation to foster device development for rare diseases. Issues relating to group purchasing organizations. Issues pertaining to Congressional Oversight inquiries from the Senate Finance Committee. Issues relating to the FDA 510(k) review process for medical devices.

S. 17 - Medical Device Access and Innovation Protection Act - Repeals the Internal Revenue Code provision, added by the Health Care and Education Reconciliation Act, that imposes an excise tax on medical devices. S. 262 - A bill to repeal the excise tax on medical device manufacturers H.R. 436 - Protect Medical Innovation Act of 2011 - Amends the Internal Revenue Code to repeal the excise tax on medical devices. H.R. 488 - Save Our Medical Devices Act of 2011 - Amends the Internal Revenue Code to repeal the excise tax on medical devices. H.R. 734 - To amend the Internal Revenue Code of 1986 to repeal the medical device tax, and for other purposes - Repeals the provision of the Internal Revenue Code, added by the Health Care and Education Reconciliation Act of 2010, that imposes an excise tax on medical devices. S. 239 - Innovate America Act - Amends the Internal Revenue Code to: (1) revise the definition of "basic research," for purposes of the research tax credit, to remove the prohibition against such research having a specific commercial objective; and (2) provide a tax credit for charitable contributions of equipment to secondary schools and technical and community colleges. Issues related to the taxation of medical devices, the R&D tax credit, and corporate tax reform. International tax issues, including, the taxation of foreign earnings of U.S. multinational corporations, and territorial tax reform proposals.

Patient Protection and Affordable Health Care Act (P.L. 111-148) - Issues relating to the implementation of this Act including Accountable Care Organizations, Physician Payment Disclosure, Patient Centered Outcomes Research Institute (PCORI), and other issues. S. 17/ H.R. 436 - Medical Device Access and Innovation Act - issues relating to the repeal of the medical device excise tax Issues relating to group purchasing organizations. Issues relating to the FDA 510(k) review process for medical devices.

S. 17 - Medical Device Access and Innovation Protection Act - Repeals the Internal Revenue Code provision, added by the Health Care and Education Reconciliation Act, that imposes an excise tax on medical devices. S. 262 - A bill to repeal the excise tax on medical device manufacturers H.R. 436 - Protect Medical Innovation Act of 2011 - Amends the Internal Revenue Code to repeal the excise tax on medical devices. H.R. 488 - Save Our Medical Devices Act of 2011 - Amends the Internal Revenue Code to repeal the excise tax on medical devices. H.R. 734 - To amend the Internal Revenue Code of 1986 to repeal the medical device tax, and for other purposes - Repeals the provision of the Internal Revenue Code, added by the Health Care and Education Reconciliation Act of 2010, that imposes an excise tax on medical devices. S. 239 - Innovate America Act - Amends the Internal Revenue Code to: (1) revise the definition of "basic research," for purposes of the research tax credit, to remove the prohibition against such research having a specific commercial objective; and (2) provide a tax credit for charitable contributions of equipment to secondary schools and technical and community colleges. Issues related to the taxation of medical devices, the R&D tax credit, and corporate tax reform. International tax issues, including, the taxation of foreign earnings of U.S. multinational corporations, and territorial tax reform proposals.

H. Con Res 34, fiscal year 2012 budget resolution, - Issues concerning Medicare and Health Reform. S. 365 - Budget Control Act of 2011 as it relates to Medicare reimbursement.

Patient Protection and Affordable Health Care Act (P.L. 111-148) - Issues relating to the implementation of this Act including Accountable Care Organizations, Physician Payment Disclosure, Patient Centered Outcomes Research Institute (PCORI), and other issues. S. 17/ H.R. 436 - Medical Device Access and Innovation Act - issues relating to the repeal of the medical device excise tax S. 239 - Innovate America Act - provisions relating to regulatory and tax improvement Humanitarian Device Reform legislation to foster device development for rare diseases. Issues relating to group purchasing organizations. Issues pertaining to Congressional Oversight inquiries from the Senate Finance Committee. Issues relating to the FDA 510(k) review process for medical devices.

Issues related to pending Free Trade Agreements with Korea, Colombia & Panama

H. Con Res 34, fiscal year 2012 budget resolution, - Issues concerning Medicare and Health Reform. S. 365 - Budget Control Act of 2011 as it relates to Medicare reimbursement.

S. 17 - Medical Device Access and Innovation Protection Act - Repeals the Internal Revenue Code provision, added by the Health Care and Education Reconciliation Act, that imposes an excise tax on medical devices. S. 262 - A bill to repeal the excise tax on medical device manufacturers H.R. 436 - Protect Medical Innovation Act of 2011 - Amends the Internal Revenue Code to repeal the excise tax on medical devices. H.R. 488 - Save Our Medical Devices Act of 2011 - Amends the Internal Revenue Code to repeal the excise tax on medical devices. H.R. 734 - To amend the Internal Revenue Code of 1986 to repeal the medical device tax, and for other purposes - Repeals the provision of the Internal Revenue Code, added by the Health Care and Education Reconciliation Act of 2010, that imposes an excise tax on medical devices. S. 239 - Innovate America Act - Amends the Internal Revenue Code to: (1) revise the definition of "basic research," for purposes of the research tax credit, to remove the prohibition against such research having a specific commercial objective; and (2) provide a tax credit for charitable contributions of equipment to secondary schools and technical and community colleges. Issues related to the taxation of medical devices, the R&D tax credit, and corporate tax reform. International tax issues, including, the taxation of foreign earnings of U.S. multinational corporations, and territorial tax reform proposals.

Patient Protection and Affordable Health Care Act (P.L. 111-148) - Issues relating to the implementation of this Act including Accountable Care Organizations, Physician Payment Disclosure, Patient Centered Outcomes Research Institute (PCORI), and other issues. S. 17/ H.R. 436 - Medical Device Access and Innovation Act - issues relating to the repeal of the medical device excise tax Issues relating to group purchasing organizations. Issues relating to the FDA 510(k) review process for medical devices.

S. 17 - Medical Device Access and Innovation Protection Act - Repeals the Internal Revenue Code provision, added by the Health Care and Education Reconciliation Act, that imposes an excise tax on medical devices. S. 262 - A bill to repeal the excise tax on medical device manufacturers H.R. 436 - Protect Medical Innovation Act of 2011 - Amends the Internal Revenue Code to repeal the excise tax on medical devices. H.R. 488 - Save Our Medical Devices Act of 2011 - Amends the Internal Revenue Code to repeal the excise tax on medical devices. H.R. 734 - To amend the Internal Revenue Code of 1986 to repeal the medical device tax, and for other purposes - Repeals the provision of the Internal Revenue Code, added by the Health Care and Education Reconciliation Act of 2010, that imposes an excise tax on medical devices. S. 239 - Innovate America Act - Amends the Internal Revenue Code to: (1) revise the definition of "basic research," for purposes of the research tax credit, to remove the prohibition against such research having a specific commercial objective; and (2) provide a tax credit for charitable contributions of equipment to secondary schools and technical and community colleges. Issues related to the taxation of medical devices, the R&D tax credit, and corporate tax reform. International tax issues, including, the taxation of foreign earnings of U.S. multinational corporations, and territorial tax reform proposals.

S. 17 - Medical Device Access and Innovation Protection Act - Repeals the Internal Revenue Code provision, added by the Health Care and Education Reconciliation Act, that imposes an excise tax on medical devices. S. 262 - A bill to repeal the excise tax on medical device manufacturers - Repeals the provision of the Internal Revenue Code, added by the Health Care and Education Reconciliation Act of 2010, that imposes an excise tax on medical devices. H.R. 436 - Protect Medical Innovation Act of 2011 - Amends the Internal Revenue Code to repeal the excise tax on medical devices. H.R. 488 - Save Our Medical Devices Act of 2011 - Amends the Internal Revenue Code to repeal the excise tax on medical devices. H.R. 734 - To amend the Internal Revenue Code of 1986 to repeal the medical device tax, and for other purposes - Repeals the provision of the Internal Revenue Code, added by the Health Care and Education Reconciliation Act of 2010, that imposes an excise tax on medical devices. S. 239 - Innovate America Act - Amends the Internal Revenue Code to: (1) revise the definition of "basic research," for purposes of the research tax credit, to remove the prohibition against such research having a specific commercial objective; and (2) provide a tax credit for charitable contributions of equipment to secondary schools and technical and community colleges. Issues related to the taxation of medical devices, the R&D tax credit, and corporate tax reform. International tax issues, including, the taxation of foreign earnings of U.S. multinational corporations, and territorial tax reform proposals.

Issues related to the taxation of foreign earnings of U.S. corporations. H.R. 4213 - the Tax Extenders Act, as it relates to the research and development tax credit. S. 3816, Creating American Jobs and Ending Offshoring Act; HR 5982, The Small Business Tax Relief Act; HR 5793, Close Foreign Tax Loopholes Act; and HR 5893, Investing in American Jobs Act, as they relate to the taxation of foreign earnings of U.S. corporations. HR 4213, the Tax Extenders Act; HR 5297, the Small Business Jobs and Credit Act; and S. 3793, the Job Creation and Tax Cuts Act, as they relate to the research and development tax credit.

H.R. 1346 - To amend the Federal food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices- provision related to federal preemption. S. 540 - A bill to amend the Federal food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices- provision related to federal preemption. H.R. 2749 - Food Safety Enhancement Act of 2009- Grants FDA the authority and resources it needs to better oversee the safety of the nations food supply. Includes provisions related to device import safety fee, registration fees and unique identifier provisions H.R. 759 - FDA Globalization Act- Grants FDA the authority and resources it needs to better oversee the safety of the nations food, cosmetic, drug and device supply. Includes provisions related to device import safety fee, registration fees and unique identifier provisions H.R. 4994 -- The Medicare and Medicaid Extenders Act of 2010 - section 112 - reauthorization of the Special Diabetes Program. Patient Protection and Affordable Care Act [P.L. 111-148] - Implementation issues concerning CER, IPAB, excise tax, prevention and wellness, disparaties, pain, payment reform provisions.

H.R. 1346 - To amend the Federal food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices- provision related to federal preemption. S. 540 - A bill to amend the Federal food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices- provision related to federal preemption. H.R. 2749 - Food Safety Enhancement Act of 2009- Grants FDA the authority and resources it needs to better oversee the safety of the nations food supply. Includes provisions related to device import safety fee, registration fees and unique identifier provisions H.R. 759 - FDA Globalization Act- Grants FDA the authority and resources it needs to better oversee the safety of the nations food, cosmetic, drug and device supply. Includes provisions related to device import safety fee, registration fees and unique identifier provisions Patient Protection and Affordable Care Act [P.L. 111-148] - Implementation issues concerning CER, IPAB, excise tax, prevention and wellness, disparaties, pain, payment reform provisions.

H.R. 4173 - Restoring American Financial Stability Act of 2010 - Provisions related to regulations of over-the-counter derivatives by endusers. S. 3217 - Restoring American Financial Stability Act of 2010 - Provisions related to regulations of over-the-counter derivatives by endusers.

H.R. 1346 - To amend the Federal food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices- provision related to federal preemption. S. 540 - A bill to amend the Federal food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices- provision related to federal preemption. H.R. 2749 - Food Safety Enhancement Act of 2009- Grants FDA the authority and resources it needs to better oversee the safety of the nations food supply. Includes provisions related to device import safety fee, registration fees and unique identifier provisions H.R. 759 - FDA Globalization Act- Grants FDA the authority and resources it needs to better oversee the safety of the nations food, cosmetic, drug and device supply. Includes provisions related to device import safety fee, registration fees and unique identifier provisions

Restoring American Financial Stability Act - Provisions related to regulations of over-the-counter derivatives by endusers.

Issues related to the taxation of foreign earnings of U.S. corporations. HR 3200, Americas Affordable Health Choices Act; HR 3590, The Patient Protection and Affordable Health Care Act; HR 3962, Affordable Health Care for America Act and HR 4872, the Reconciliation Act of 2010, and issues related to the taxation of medical devices. HR 4213, the Tax Extenders Act, as it relates to the research and development tax credit.

HR 1346 - To amend the Federal food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices- provision related to federal preemption. S. 540 - A bill to amend the Federal food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices- provision related to federal preemption. HR 756- National Pain Care Policy Act of 2009- Addresses important barriers to proper pain management by improving pain care research, education, outreach and care. S 660- National Pain Care Policy Act of 2009- Addresses important barriers to proper pain management by improving pain care research, education, outreach and care. HR 3090-Health Equity & Accountability Act of 2009- Provides for the elimination of racial and ethnic health disparities. HR 1213- SAAAVE Act of 2009- Provides technical corrections to the original legislation which unlinks AAA screening with the Welcome to Medicare Physical Exam and extends the one-time benefit to 65-75 year old at-risk Medicare beneficiaries. HR 2749- Food Safety Enhancement Act of 2009- Grants FDA the authority and resources it needs to better oversee the safety of the nations food supply. Includes provisions related to device import safety fee, registration fees and unique identifier provisions HR 759- FDA Globalization Act- Grants FDA the authority and resources it needs to better oversee the safety of the nations food, cosmetic, drug and device supply. Includes provisions related to device import safety fee, registration fees and unique identifier provisions S 1213 - A bill to amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Patient-Centered Outcomes Research Trust Fund, and for other purposes - provisions related to comparative effectiveness research. S. 1796 - America's Healthy Future Act of 2009 - An original bill to provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes. Contains provisions related to medical device excise tax. S.1679 - Affordable Health Choices Act - contains provisions related to health care reform. H.R. 3200, Americas Affordable Health Choices Act of 2009, H.R. 3590, the Patient Protection and Affordable Care Act, and H.R. 3962, The Affordable Health Care for Americans Act, as they relate to the Independent Payment Advisory Commission, Comparative Effectiveness Research, National Device Registry, Pain Care Management, Medicare Prevention Screening Benefits, Medicare Shared Saving Pilots and Physician Payment Disclosure. H.R. 3590, Patient Protection and Affordable Care Act and H.R. 4872, Health Care and Education Reconciliation Act of 2010 as they relate to device excise tax, comparative effectiveness research, Independent Payment Advisory Board, AAA provisions, prevention and wellness, pain management, health disparity provisions, delivery and payment system reforms, physician-payment disclosure.

H.R. 3200, Americas Affordable Health Choices Act of 2009, H.R. 3590, the Patient Protection and Affordable Care Act, and H.R. 3962, The Affordable Health Care for Americans Act, as they relate to new fees on manufacturers of medical devices and to taxation of employer-sponsored health coverage. Issues related to the taxation of foreign earnings of U.S. multinational corporations. H.R. 4213, the Tax Extenders Act of 2009, as it relates to the research and development tax credit.

S 272 - Bill to amend the Commodity Exchange Act to ensure that all agreements, contracts, and transactions with respect to commodities are carried out on a regulated exchange - provisions related to regulation of derivatives. H.R.977 Amends the Commodity Exchange Act to bring greater transparency and accountability to commodity markets - provisions related to regulation of derivatives. Over-the-Counter Derivatives Markets Act of 2009. H.R. 4173, Wall Street Reform & Consumer Protection Act - legislation including provisions to regulate over-the-counter derivatives markets

Issues relating to the taxation of foreign earnings of U.S. Corporations. H.R. 3200, the America's Affordable Health Choices Act of 2009, and issues related to the taxation of medical devices. S. 1796 - America's Healthy Future Act of 2009 - An original bill to provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes. Contains provisions related to medical device excise tax.

HR 1346 - To amend the Federal food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices- provision related to federal preemption. S. 540 - A bill to amend the Federal food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices- provision related to federal preemption. HR 756- National Pain Care Policy Act of 2009- Addresses important barriers to proper pain management by improving pain care research, education, outreach and care. S 660- National Pain Care Policy Act of 2009- Addresses important barriers to proper pain management by improving pain care research, education, outreach and care. HR 3090-Health Equity & Accountability Act of 2009- Provides for the elimination of racial and ethnic health disparities. HR 1380- Josh Miller Hearts Act- Provides federal grants and training for automated external defibrillators in elementary and secondary schools. S. 1197 Josh Miller Hearts Act- Provides federal grants and training for automated external defibrillators in elementary and secondary schools. S 660- National Pain Care Policy Act of 2009- Addresses important barriers to proper pain management by improving pain care research, education, outreach and care. HR 1213- SAAAVE Act of 2009- Provides technical corrections to the original legislation which unlinks AAA screening with the Welcome to Medicare Physical Exam and extends the one-time benefit to 65-75 year old at-risk Medicare beneficiaries. HR 2749- Food Safety Enhancement Act of 2009- Grants FDA the authority and resources it needs to better oversee the safety of the nations food supply. Includes provisions related to device import safety fee, registration fees and unique identifier provisions HR 759- FDA Globalization Act- Grants FDA the authority and resources it needs to better oversee the safety of the nations food, cosmetic, drug and device supply. Includes provisions related to device import safety fee, registration fees and unique identifier provisions HR 3200- Americas Affordable Health Choices Act of 2009 - To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes. Interests include comparative effectiveness research, physician payment disclosure requirements, device registries, AAA benefit, and pain management. S 1213 - A bill to amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Patient-Centered Outcomes Research Trust Fund, and for other purposes - provisions related to comparative effectiveness research. S. 1796 - America's Healthy Future Act of 2009 - An original bill to provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes. Contains provisions related to medical device excise tax. S.1679 - Affordable Health Choices Act - contains provisions related to health care reform.

S 272 - Bill to amend the Commodity Exchange Act to ensure that all agreements, contracts, and transactions with respect to commodities are carried out on a regulated exchange - provisions related to regulation of derivatives. H.R.977 Amends the Commodity Exchange Act to bring greater transparency and accountability to commodity markets - provisions related to regulation of derivatives.

H.Con.Res. 85 and S.Con.Res. 13, the FY 2010 budget resolution, and issues relating to the taxation of foreign earnings of U.S. multinational corporations.

HR 1346 - To amend the Federal food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices- provision related to federal preemption. S. 540 - A bill to amend the Federal food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices- provision related to federal preemption. HR 756- National Pain Care Policy Act of 2009- Addresses important barriers to proper pain management by improving pain care research, education, outreach and care. S 660- National Pain Care Policy Act of 2009- Addresses important barriers to proper pain management by improving pain care research, education, outreach and care. HR 3090-Health Equity & Accountability Act of 2009- Provides for the elimination of racial and ethnic health disparities. HR 1390- Josh Miller Hearts Act- Provides federal grants and training for automated external defibrillators in elementary and secondary schools. HR 1390- Josh Miller Hearts Act- Provides federal grants and training for automated external defibrillators in elementary and secondary schools. S. 1197 Josh Miller Hearts Act- Provides federal grants and training for automated external defibrillators in elementary and secondary schools. S 660- National Pain Care Policy Act of 2009- Addresses important barriers to proper pain management by improving pain care research, education, outreach and care. HR 1213- SAAAVE Act of 2009- Provides technical corrections to the original legislation which unlinks AAA screening with the Welcome to Medicare Physical Exam and extends the one-time benefit to 65-75 year old at-risk Medicare beneficiaries. HR 2749- Food Safety Enhancement Act of 2009- Grants FDA the authority and resources it needs to better oversee the safety of the nations food supply. Includes provisions related to device import safety fee, registration fees and unique identifier provisions HR 759- FDA Globalization Act- Grants FDA the authority and resources it needs to better oversee the safety of the nations food, cosmetic, drug and device supply. Includes provisions related to device import safety fee, registration fees and unique identifier provisions HR 3200- Americas Affordable Health Choices Act of 2009 - To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes. Interests include comparative effectiveness research, physician payment disclosure requirements, device registries, AAA benefit, and pain management. S 1213 - A bill to amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Patient-Centered Outcomes Research Trust Fund, and for other purposes - provisions related to comparative effectiveness research

HR 1346 - To amend the Federal food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices- provision related to federal preemption. S. 540 - A bill to amend the Federal food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices- provision related to federal preemption. HR 756 - To amend the Public Health Service Act with respect to pain care - provisions related to pain care management and treatment S. 660 - A bill to amend the Public Health Service Act with respect to pain care - provisions related to pain care management and treatment S.391- A bill to provide affordable, guaranteed private health coverage that will make Americans healthier and can never be taken away. H.R.1321- To provide affordable, guaranteed private health coverage that will make Americans healthier and can never be taken away. HR 759 - To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food, drugs, devices, and cosmetics in the global market, and for other purposes - provisions related to proposed user fees to pay for increased inspection of products HR 1213 - To amend title XVIII of the Social Security Act to provide that the Medicare initial preventive physical examination not be required for a referral with respect to ultrasound screening for abdominal aortic aneurysms and to provide for such screening with respect to at-risk Medicare beneficiaries between the ages of 65 and 75 - provisions related to unlinking the AAA screening with the Welcome to Medicare Physicial Exam and extension of the one-time benefit to at-risk 65-75 year old Medicare beneficiaries. Call to Action Health Reform 2009, as presented by Senate Finance Committee Chairman Baucus.

H.R. 3014-Health Disparities, provisions relating to the treatment of heart disease patients in minority populations with a focus on SCA; S 1576-Health Disparities, provisions relating to the treatment of heart disease patients in minority populations with a focus on SCA; H.R. 2994-National Pain Care Policy Act of 2008, provisions related to pain care management and treatment;H.R. 6381- Medical Device Safety Act - provision related to preserving statutory federal preemption; S. 3398 - Medical Device Safety Act - provision related to preserving statutory federal preemption; S. 3387 - National Pain Care Policy Act of 2008 - provisions related to pain care management and treatment S. 3408 - Comparative Effectiveness Research Act of 2008 - provisions related to the establishment of a new entity to conduct comparative effectiveness research. S. 3409 - Drug and Device Accountability Act of 2008 - provisions related to device and drug import safety H.R. 4926 - Josh Miller Hearts Act - provisions related to establishing a grant program to ensure every elementary and secondary school in the country can obtain AEDs. H.R. 5839 - Safeguarding America's Pharmaceuticals Act of 2008 - provisions that might affect combination products H.R. 1028 - To create a Rural Policing Institute as part of the Federal Law Enforcement Training Center- provisions that might affect combination products H.R. 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007 - provisions that might affect combination products S. 1695 - Follow-on Biologics - provisions that might affect combination products S. 1693 - Health Information Technology - provisions related to enhancing the adoption of nationwide interoperable health information technology system, improving health care quality and reducing health care costs in the United States. H.R. 3800 - Promoting Health Information Technology Act - provisions related to advancing the adoption of nationwide interoperable health information technology system, improving health care quality and reducing health care costs in the United States. H.R. 2184 - Enhanced Healthcare Value for All Act of 2007- provisions to expand comparative effectiveness research S.2221 - Transparency in Medical Device Pricing Act - provisions related to pricing for medical devices S.2029 - Physician Payments Sunshine Act of 2007- provisions related to providing transparency in the relationship between physicians and manufacturers of drugs, devices, or medical supplies H.R. 3023 - Drug and Medical Device Company Gift Disclosure Act - provisions requiring manufacturers, packers and distributors of prescription drugs and medical devices to disclose certain gifts provided in connection with detailing, promotional, or other marketing activities, and for other purposes H.R. 5839 - Safeguarding America's Pharmaceuticals Act. Provisions that require tagging of pharmaceuticals with standardized numerical identifiers to track drug in all parts of supply chain. S. 3568 - To amend the Controlled Substances Act relative to the use of intrathecal pumps.

H.R. 3014-Health Disparities, provisions relating to the treatment of heart disease patients in minority populations with a focus on SCA; S 1576-Health Disparities, provisions relating to the treatment of heart disease patients in minority populations with a focus on SCA; H.R. 2994-National Pain Care Policy Act of 2008, provisions related to pain care management and treatment;H.R. 6381- Medical Device Safety Act - provision related to preserving statutory federal preemption; S. 3398 - Medical Device Safety Act - provision related to preserving statutory federal preemption; S. 3387 - National Pain Care Policy Act of 2008 - provisions related to pain care management and treatment S. 3408 - Comparative Effectiveness Research Act of 2008 - provisions related to the establishment of a new entity to conduct comparative effectiveness research. S. 3409 - Drug and Device Accountability Act of 2008 - provisions related to device and drug import safety H.R. 4926 - Josh Miller Hearts Act - provisions related to establishing a grant program to ensure every elementary and secondary school in the country can obtain AEDs. H.R. 5839 - Safeguarding America's Pharmaceuticals Act of 2008 - provisions that migt affect combination products H.R. 1028 - To create a Rural Policing Institute as part of the Federal Law Enforcement Training Center- provisions that might affect combination products H.R. 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007 - provisions that might affect combination products S. 1695 - Follow-on Biologics - provisions that might affect combination products S. 1693 - Health Information Technology - provisions related to enhancing the adoption of nationwide interoperable health information technology system, improving health care quality and reducing health care costs in the United States. H.R. 3800 - Promoting Health Information Technology Act - provisions related to advancing the adoption of nationwide interoperable health information technology system, improving health care quality and reducing health care costs in the United States. H.R. 2184 - Enhanced Healthcare Value for All Act of 2007- provisions to expand comparative effectiveness research S.2221 - Transparency in Medical Device Pricing Act - provisions related to pricing for medical devices S.2029 - Physician Payments Sunshine Act of 2007- provisions related to providing transparency in the relationship between physicians and manufacturers of drugs, devices, or medical supplies H.R. 3023 - Drug and Medical Device Company Gift Disclosure Act - provisions requiring manufacturers, packers and distributors of prescription drugs and medical devices to disclose certain gifts provided in connection with detailing, promotional, or other marketing activities, and for other purposes

H.R. 3014-Health Disparities, provisions relating to the treatment of heart disease patients in minority populations with a focus on SCA; S 1576-Health Disparities, provisions relating to the treatment of heart disease patients in minority populations with a focus on SCA; H.R. 2994-Pain care, provisions related to pain care management and treatment;H.R. 6381- Medical Device Safety Act - provision related to preserving statutory federal preemption; H.R. 4926 - Josh Miller Hearts Act - provisions related to establishing a grant program to ensure every elementary and secondary school in the country can obtain AEDs. H.R. 5839 - Safeguarding America's Pharmaceuticals Act of 2008 - provisions that migt affect combination products H.R. 1028 - Follow-on Biologics - provisions that might affect combination products H.R. 1956 - Follow-on Biologics - provisions that might affect combination products S. 1695 - Follow-on Biologics - provisions that might affect combination products H.R. 5658 - National Defense Authorization Act for FY2009 - provisions related to development of pain care plan for the military H.R.5465- Title: To require the Department of Defense to implement a pain care initiative, provisions related to pain care S. 1693 - Health Information Technology, Provisions related to enhancing the adoption of nationwide interoperable health information technology system, improving health care quality and reducing health care costs in the United States. H.R. 3800 - Health Information Technology, Provisions related to advancing the adoption of nationwide interoperable health information technology system, improving health care quality and reducing health care costs in the United States. H.R. 2184 - Enhanced Healthcare Value for All Act of 2007, provisions to expand comparative effectiveness research S.2221 - Transparency in Medical Device Pricing Act, provisions related to pricing for medical devices S.334-Health care reform, provisions related to providing affordable, guaranteed private health coverage S.2029 - Physician Payments Sunshine Act of 2007, provisions related to providing transparency in the relationship between physicians and manufacturers of drugs, devices, or medical supplies H.R. 3023 - Transparency, provisions requiring manufacturers, packers and distributors of prescription drugs and medical devices to disclose certain gifts provided in connection with detailing, promotional, or other marketing activities, and for other purposes S. 1693 - Health Information Technology, Provisions related to enhancing the adoption of nationwide interoperable health information technology system, improving health care quality and reducing health care costs in the United States. Medical Device Import Safety Act - provisions related to federal preemption H.R. 1538 - Pain care, provisions of the bill related to creating a center of excellence for traumatic brain injury with a comprehensive pain management program Safety and Quality of Medical Products and their components (Sen. Kennedy)- medical device monitoring provisions that would included increased user fees for medical manufacturers. Food and Drug Administration Globalization Act (Dingell) - medical device monitoring provisions that would included increased user fees for medical manufacturers. AAA Screening and Welcome to Medicare Physical Exam - monitor AAA screening related legislation

H.R. 3014-Health Disparities, provisions relating to the treatment of heart disease patients in minority populations with a focus on SCA; S 1576-Health Disparities, provisions relating to the treatment of heart disease patients in minority populations with a focus on SCA; H.R. 2994-Pain care, provisions related to pain care management and treatment; H.R.5465- Title: To require the Department of Defense to implement a pain care initiative, provisions related to pain care S. 1693 - Health Information Technology, Provisions related to enhancing the adoption of nationwide interoperable health information technology system, improving health care quality and reducing health care costs in the United States. H.R. 3800 - Health Information Technology, Provisions related to advancing the adoption of nationwide interoperable health information technology system, improving health care quality and reducing health care costs in the United States. H.R. 2184 - Enhanced Healthcare Value for All Act of 2007, provisions to expand comparative effectiveness research S.2221 - Transparency in Medical Device Pricing Act, provisons related to pricing for medical devices S.334-Health care reform, provisions related to providing affordable, guaranteed private health coverage S.2029 - Physician Payments Sunshine Act of 2007, provisions related to providing transparency in the relationship between physicians and manufacturers of drugs, devices, or medical supplies H.R. 3023 - Transparency, provisions requiring manufacturers, packers and distributors of prescription drugs and medical devices to disclose certain gifts provided in connection with detailing, promotional, or other marketing activities, and for other purposes S. 1082, Food and Drugs Administration Revitalization Act, extending the device user fee program among other purposes H.R.3580 - provision related to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and for medical devices, to enhance the postmarket authorities of the Food and Drug Administration with respect to the safety of drugs, and for other purposes. S. 1693 - Health Information Technology, Provisions related to enhancing the adoption of nationwide interoperable health information technology system, improving health care quality and reducing health care costs in the United States. Medical Device Safety Act - provisions related to federal preemption H.R. 1538 - Pain care, provisions of the bill related to creating a center of excellence for traumatic brain injury with a comprehensive pain management program

H.R. 3014-Health Disparities, provisions relating to the treatment of heart disease patients in minority populations with a focus on SCA; S 1576-Health Disparities, provisions relating to the treatment of heart disease patients in minority populations with a focus on SCA; H.R. 2994-Pain care, provisions related to pain care management and treatment; H.R.5465- Title: To require the Department of Defense to implement a pain care initiative, provisions related to pain care S. 1693 - Health Information Technology, Provisions related to enhancing the adoption of nationwide interoperable health information technology system, improving health care quality and reducing health care costs in the United States. H.R. 3800 - Health Information Technology, Provisions related to advancing the adoption of nationwide interoperable health information technology system, improving health care quality and reducing health care costs in the United States. H.R. 2184 - Enhanced Healthcare Value for All Act of 2007, provisions to expand comparative effectiveness research S.2221 - Transparency in Medical Device Pricing Act, provisons related to pricing for medical devices S.334-Health care reform, provisions related to providing affordable, guaranteed private health coverage S.2029 - Physician Payments Sunshine Act of 2007, provisions related to providing transparency in the relationship between physicians and manufacturers of drugs, devices, or medical supplies H.R. 3023 - Transparency, provisions requiring manufacturers, packers and distributors of prescription drugs and medical devices to disclose certain gifts provided in connection with detailing, promotional, or other marketing activities, and for other purposes S. 1082, Food and Drugs Administration Revitalization Act, extending the device user fee program among other purposes H.R.3580 - provision related to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and for medical devices, to enhance the postmarket authorities of the Food and Drug Administration with respect to the safety of drugs, and for other purposes. S. 1693 - Health Information Technology, Provisions related to enhancing the adoption of nationwide interoperable health information technology system, improving health care quality and reducing health care costs in the United States. Medical Device Safety Act - provisions related to federal preemption H.R. 1538 - Pain care, provisions of the bill related to creating a center of excellence for traumatic brain injury with a comprehensive pain management program